#MINDACT - Twitter Hashtag

5 months ago

https://t.co/lWNTmYTttX #mindact 2025 cognitive warfare on the Americans by corruption facilitating a hit placed for personal business ventures. They seek to place body tracking markers. On the human making it feel like a natural bodily occurrence. For stealth tracking. #havanasyndrome is a #neuroweapon

2

6

3

0

147

Christine Desmedt @ChristineDesme2

almost 3 years ago

We thank all collaborators from the #ICGC, #METABRIC, #MINDACT and #BioKey studies @Onco_KULeuven @SerenaNikZainal @LambrechtsDlab @HansWildiers @AbhishekDGarg @GeukensTatjana @VanBaelenKaren @maximdeschepper, Elia Biganzoli and many others.

1

7

0

551

iSanidad

@isanidad

over 3 years ago

#Oncología| El test #genómico MammaPrint es una prueba que analiza 7️⃣ 0️⃣ genes que pronostica el riesgo de recaída de las #pacientes con #cáncerdemama @JCO_ASCO @ICO_oncologia @NCCN #MINDACT https://t.co/0cDmZWOdwI

0

2

0

873

Mathias Karlsson

@mathiaskarlsson

over 3 years ago

Detta är avslutningen på ett långt, relativt argt mail till skolan. 1h senare fick jag skakigt samtal där en liten ursäkt ”nästan” hördes mellan orden. Nu möte med ett gäng lärare kl 14.30. Wish me luck! #psykiskohälsa #hälsa #skolan #totalhaveri #mindact #hemasittare

mathiaskarlsson's tweet photo. Detta är avslutningen på ett långt, relativt argt mail till skolan. 1h senare fick jag skakigt samtal där en liten ursäkt ”nästan” hördes mellan orden.
Nu möte med ett gäng lärare kl 14.30. Wish me luck! #psykiskohälsa #hälsa #skolan #totalhaveri #mindact #hemasittare https://t.co/0tah22bxUy

1

7

0

264

Mathias Karlsson

@mathiaskarlsson

over 3 years ago

Vad vill jag egentligen säga med detta så här en måndag morgon? Jo, de är så många där ute som kämpar i tysthet, som inte syns. Ett litet ”hej” räddar en dag, en vecka. Ett ”Hur mår du?” kan förändra hela livet. Ta hand om varandra❤️ #psykiskohälsa #depression #mindact #kärlek

7

18

0

432

IR @itrisabel

over 4 years ago

It Confirmes results from #MINDACT study…age makes a difference @ESSOnews @KarakatsanisA @DrFionaTsang @EJSO @NEJM

Andreas Karakatsanis (he/him) @KarakatsanisA

over 4 years ago

Postmenopausal women with up to 3+LNs and low genomic risk score do not benefit from chemo. @ejsotweets @ESSOnews @marios_tasoulis @itrisabel @MalinASund @OlofssonBagge @raaudisio @DrFionaTsang https://t.co/KGAvsjh52d

1

15

6

1

0

8

1

0

Agendia

@Agendia

over 4 years ago

#MINDACT - Showed that #MammaPrint Low Risk patients are unlikely to benefit from chemotherapy, including those with up to three positive lymph nodes. It confirmed that Ultra Low Risk patients have excellent outcomes, even without any systemic therapy. https://t.co/YIUm8bDfmY

Agendia's tweet photo. #MINDACT - Showed that #MammaPrint Low Risk patients are unlikely to benefit from chemotherapy, including those with up to three positive lymph nodes. It confirmed that Ultra Low Risk patients have excellent outcomes, even without any systemic therapy. https://t.co/YIUm8bDfmY https://t.co/WHYAp81qBT

0

3

0

Sudha Marimuthu @MarimuthuSudha

almost 5 years ago

#mentalhealth #mindact #tnpolice #KavalarNanban #positivity சிறந்த மனநலம் - இந்த முயற்சியில் எங்களின் சிறிய பங்களிப்பு, தமிழக காவல் அதிகாரிகளுக்கான ஆண்ட்ராய்டு இலவச செயலி.- kavalar Nanban @CMOTamilnadu @mkstalin @tnpoliceoffl https://t.co/gRAaGkslC4

MarimuthuSudha's tweet photo. #mentalhealth #mindact #tnpolice #KavalarNanban #positivity சிறந்த மனநலம் - இந்த முயற்சியில் எங்களின் சிறிய பங்களிப்பு, தமிழக காவல் அதிகாரிகளுக்கான ஆண்ட்ராய்டு இலவச செயலி.- kavalar Nanban @CMOTamilnadu @mkstalin @tnpoliceoffl
https://t.co/gRAaGkslC4 https://t.co/yIMziSVCN9

1

3

1

0

Agendia

@Agendia

almost 5 years ago

Most Views On Oncology Tube - Laura van ’t Veer, Ph.D. speaks about #MammaPrint 70-gene signature as an aid for treatment decisions in early #breastcancer: updated results of the phase 3 randomised #MINDACT trial with an exploratory analysis by age. https://t.co/kr6mQSSDwR

1

5

1

0

Els Dewulf @els_dewulf

almost 5 years ago

Use of GEP in clinical practice #bcsm #pinpointcase #genomicprofiling #mindact #rxponder

Mirrors of Medicine

@mirrorsmed

almost 5 years ago

• 57 yo 👩‍🦰, postmenopausal, HR+ HER2- EBC • cT2N0M0, G2, Ki67 15%, ER 100%, PgR 10% • BCS+SLNB: pT1c(m) (17 mm) pN1a (1/4 sn), R0, no LVI Check the opinion of the expert panel and @c_sotiriou 🌐https://t.co/xM7V1pPUza #PinPointCases #bcsm #Oncoalert

0

5

2

0

2

0

Agendia

@Agendia

almost 5 years ago

Josephine Lopes Cardozo, Ph.D. from the Netherlands Cancer Institute speaks about the #ASCO21 Abstract - Outcome of patients with an ultralow risk 70-gene signature in the #MINDACT trial. View full video here: https://t.co/Rh4KRZ6lrK #BreastCancer #MammaPrint #Cancer

0

4

1

0

Yoshi ｜思考と行動の調律コンサルタント｜パートナーCOO @y_maemu

about 5 years ago

#ASCO21 発表内容について #NSABP-B42 #ExtendedET #MINDACT #UltraLow https://t.co/2XMUs5Y7uf #DNAチップ研究所 #国内検査受託 #マンマプリント #ブループリント #MammaPrint #BluePrit

y_maemu's tweet photo. #ASCO21 発表内容について
#NSABP-B42 #ExtendedET #MINDACT #UltraLow

https://t.co/2XMUs5Y7uf

#DNAチップ研究所 #国内検査受託 #マンマプリント #ブループリント #MammaPrint #BluePrit https://t.co/DE1rugnT2h

0

2

1

0

Agendia

@Agendia

about 5 years ago

Analysis of #MINDACT Study Confirms #MammaPrint Accurately Identifies Extremely Indolent Ultra Low Risk #BreastCancers. Learn more here: https://t.co/X9JsBzLgYK #explorethe150

0

3

0

Tatiana Prowell, MD @tmprowell

about 5 years ago

#ASCO21. Clarification of my point re #MINDACT b/c colleague just said "But this is looking at genomics. Isn't that the goal?" Yes. My point here: because > half of distant mets/deaths in early ER+ #bcsm come in yrs 8-20+, an 8y f/u is too short to say omission of ET is fine.

0

6

0

2

0

Matteo Lambertini, MD PhD @matteolambe

about 5 years ago

Early #BreastCancer Oral Abstract session at #ASCO21: excellent and much needed discussion by @FAndreMD on how to interpret #MINDACT and #B42 results integrating clinical and genomic data to improve tailoring of adjuvant #EndocrineTherapy @OncoAlert #bcsm @GustaveRoussy

matteolambe's tweet photo. Early #BreastCancer Oral Abstract session at #ASCO21: excellent and much needed discussion by @FAndreMD on how to interpret #MINDACT and #B42 results integrating clinical and genomic data to improve tailoring of adjuvant #EndocrineTherapy

@OncoAlert #bcsm @GustaveRoussy https://t.co/dEuQHMfFaG

0

20

5

0

Tatiana Prowell, MD @tmprowell

about 5 years ago

#ASCO21. Important caveat: before omitting endocrine tx in #bcsm based on #MINDACT oral, remember 2017 Pan et al meta-analysis (N=67K) of rec risk after stopping ET found even in N0-1 > half the distant mets/deaths occur AFTER yr 10 & abs risk is not low. https://t.co/5snkdgVBz5

tmprowell's tweet photo. #ASCO21. Important caveat: before omitting endocrine tx in #bcsm based on #MINDACT oral, remember 2017 Pan et al meta-analysis (N=67K) of rec risk after stopping ET found even in N0-1 > half the distant mets/deaths occur AFTER yr 10 & abs risk is not low. https://t.co/5snkdgVBz5 https://t.co/hOBePUXivn

3

17

5

2

0

Tatiana Prowell, MD @tmprowell

about 5 years ago

#ASCO21. In early #bcsm #MINDACT trial (N~6.7K), at ~8y f/u, the 15% of pts classified as ultra-low risk by Mammaprint 70-gene had few distant mets/deaths w/ endocrine tx alone or no systemic tx, regardless of clin risk. We can prob give fewer pts endo tx. #PatientExpererience

tmprowell's tweet photo. #ASCO21. In early #bcsm #MINDACT trial (N~6.7K), at ~8y f/u, the 15% of pts classified as ultra-low risk by Mammaprint 70-gene had few distant mets/deaths w/ endocrine tx alone or no systemic tx, regardless of clin risk. We can prob give fewer pts endo tx. #PatientExpererience https://t.co/g3kifR5vAH

0

7

5

2

0

patty spears @paspears88

about 5 years ago

Another busy day today @ASCO with a marathon early breast cancer session on now #ASCO21 Looking forward to #OlympiA during the Plenary Session. #mindact #BCI and #mammoprint up first #bcsm

paspears88's tweet photo. Another busy day today @ASCO with a marathon early breast cancer session on now #ASCO21 Looking forward to #OlympiA during the Plenary Session. #mindact #BCI and #mammoprint up first #bcsm https://t.co/Hkws7P8vmA

0

12

3

0

Gaia Griguolo @GaiaGriguolo

about 5 years ago

#ASCO21 #MINDACT 15% of pts were ultralow risk 157 ultralow pts NOT receiving ET nor CT -> 97.8% DMFI at 8 years Is there space to start thinking about de-escalating ET? @OncoAlert #bcsm